Olema raises $209m for IPO
San Francisco-based Olema, a biopharmaceutical company focused on women’s cancers, has raised $209 million for its IPO after pricing its 11 million shares at $19 per share.
19 November 2020•3 mins read
San Francisco-based Olema, a biopharmaceutical company focused on women’s cancers, has raised $209 million for its IPO after pricing its 11 million shares at $19 per share.
